Electronic Prescribing and Electronic Transmission of Discharge Medication Lists

NCT ID: NCT00603070

Last Updated: 2012-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

130 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-03-31

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is twofold:

1. to measure the effects of transitioning from one electronic prescribing system to another in the ambulatory setting on medication errors and human-computer interactions
2. to evaluate the impact of electronic transmission of discharge medication lists to the ambulatory setting on medication discrepancies and adverse drug events

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medication Errors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

All physicians and nurse practitioners at 1 ambulatory care clinics

E-prescribing system

Intervention Type OTHER

Transition from home-grown to vendor-based ambulatory e-prescribing systems

2

All physicians and nurse practitioners at 1 ambulatory care clinics

Electronic transmission of medication discharge lists

Intervention Type OTHER

Patient discharge medication lists will be transmitted upon discharge from their inpatient medical record to their outpatient medical record and their outpatient provider will be notified of this transmission.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

E-prescribing system

Transition from home-grown to vendor-based ambulatory e-prescribing systems

Intervention Type OTHER

Electronic transmission of medication discharge lists

Patient discharge medication lists will be transmitted upon discharge from their inpatient medical record to their outpatient medical record and their outpatient provider will be notified of this transmission.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

WebCIS CLIMACS EpicCare Eclypsis

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Physicians or nurse practitioners with at least 4 clinic sessions per week
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Agency for Healthcare Research and Quality (AHRQ)

FED

Sponsor Role collaborator

New York Presbyterian Hospital

OTHER

Sponsor Role collaborator

Columbia University

OTHER

Sponsor Role collaborator

Oregon Health and Science University

OTHER

Sponsor Role collaborator

Weill Medical College of Cornell University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rainu Kaushal, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Weill Medical College of Cornell University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Weill Cornell Internal Medicine Associates

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Abramson EL, Malhotra S, Osorio SN, Edwards A, Cheriff A, Cole C, Kaushal R. A long-term follow-up evaluation of electronic health record prescribing safety. J Am Med Inform Assoc. 2013 Jun;20(e1):e52-8. doi: 10.1136/amiajnl-2012-001328. Epub 2013 Apr 11.

Reference Type DERIVED
PMID: 23578816 (View on PubMed)

Abramson EL, Patel V, Malhotra S, Pfoh ER, Nena Osorio S, Cheriff A, Cole CL, Bunce A, Ash J, Kaushal R. Physician experiences transitioning between an older versus newer electronic health record for electronic prescribing. Int J Med Inform. 2012 Aug;81(8):539-48. doi: 10.1016/j.ijmedinf.2012.02.010. Epub 2012 Mar 30.

Reference Type DERIVED
PMID: 22465355 (View on PubMed)

Abramson EL, Malhotra S, Fischer K, Edwards A, Pfoh ER, Osorio SN, Cheriff A, Kaushal R. Transitioning between electronic health records: effects on ambulatory prescribing safety. J Gen Intern Med. 2011 Aug;26(8):868-74. doi: 10.1007/s11606-011-1703-z. Epub 2011 Apr 16.

Reference Type DERIVED
PMID: 21499828 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R18HS017029-01

Identifier Type: AHRQ

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Reducing Transition Drug Risk
NCT00370916 COMPLETED NA